|
1
|
Islami F, Torre LA and Jemal A: Global
trends of lung cancer mortality and smoking prevalence. Transl Lung
Cancer Res. 4:327–338. 2015.PubMed/NCBI
|
|
2
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: The new IASLC/ATS/ERS international
multidisciplinary lung adenocarcinoma classification. J Thoracic
Oncol. 6:244–285. 2011. View Article : Google Scholar
|
|
3
|
Tang ER, Schreiner AM and Pua BB: Advances
in lung adenocarcinoma classification: A summary of the new
international multidisciplinary classification system
(IASLC/ATS/ERS). J Thorac Dis. 6 Suppl 5:S489–S501. 2014.PubMed/NCBI
|
|
4
|
Pikin OV, Ryabov AB, Trakhtenberg AK,
Glushko VA, Kolbanov KI, Amiraliev AM, Barmin VV and Tukvadze ZG:
Analysis of postoperative complications after pneumo-n-ectomy using
thoracic morbidity and mortality (tmm) system in nsclc patients for
a 5-year period. Khirurgiia (Mosk). 23–27. 2016.(In Russian).
PubMed/NCBI
|
|
5
|
Akthar AS, Ferguson MK, Koshy M,
Vigneswaran WT and Malik R: Limitations of PET/CT in the detection
of occult N1 metastasis in clinical stage I(T1-2aN0) non-small cell
lung cancer for staging prior to stereotactic body radiotherapy.
Technol Cancer Res Treat. 16:15–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Renaud S, Falcoz PE, Olland A, Reeb J,
Santelmo N and Massard G: Mediastinal downstaging after induction
treatment is not a significant prognostic factor to select patients
who would benefit from surgery: The clinical value of the lymph
node ratio. Interact Cardiovasc Thorac Surg. 20:222–227. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu S, Yan C, Yang X, He S, Liu J, Qin C,
Huang C, Lu Y, Tian Z and Jia L: Pharmacoproteomic analysis reveals
that metapristone (RU486 metabolite) intervenes E-cadherin and
vimentin to realize cancer metastasis chemoprevention. Sci Rep.
6:223882016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Liang D, Fan J, Lian X, Zhao Y,
Wang X, Chi ZH and Zhang P: Zinc attenuates tubulointerstitial
fibrosis in diabetic nephropathy via inhibition of HIF through
PI-3K signaling. Biol Trace Elem Res. 173:372–383. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu S, Yang H, Chen Y, He B and Chen Q:
Krüppel-like factor 4 enhances sensitivity of cisplatin to lung
cancer cells and inhibits regulating epithelial-to-mesenchymal
transition. Oncol Res. 24:81–87. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG,
Zhang J and Tao HQ: MicroRNA-145-5p inhibits gastric cancer
invasiveness through targeting N-cadherin and ZEB2 to suppress
epithelial-mesenchymal transition. Onco Targets Ther. 9:2305–2315.
2016.PubMed/NCBI
|
|
11
|
Zhou JP, Gao ZL, Zhou ML, He MY, Xu XH,
Tao DT, Yang CC and Liu LK: Snail interacts with Id2 in the
regulation of TNF-α-induced cancer cell invasion and migration in
OSCC. Am J Cancer Res. 5:1680–1691. 2015.PubMed/NCBI
|
|
12
|
Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ,
Wang CY, Zhang HM, Zhang RX, Zhang JJ, et al: LncRNA HULC enhances
epithelial-mesenchymal transition to promote tumorigenesis and
metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1
signaling pathway. Oncotarget. 7:42431–42446. 2016.PubMed/NCBI
|
|
13
|
Ha JH, Ward JD, Radhakrishnan R, Jayaraman
M, Song YS and Dhanasekaran DN: Lysophosphatidic acid stimulates
epithelial to mesenchymal transition marker Slug/Snail2 in ovarian
cancer cells via Gαi2, Src, and HIF1α signaling nexus. Oncotarget.
7:37664–37679. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zidar N, Boštjančič E, Jerala M, Kojc N,
Drobne D, Štabuc B and Glavač D: Down-regulation of microRNAs of
the miR-200 family and up-regulation of Snail and Slug in
inflammatory bowel diseases - hallmark of epithelial-mesenchymal
transition. J Cell Mol Med. 20:1813–1820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Liu J, Ying X, Lin PC and Zhou BP:
Twist-mediated epithelial-mesenchymal transition promotes breast
tumor cell invasion via inhibition of hippo pathway. Sci Rep.
6:246062016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Roy BC, Kohno T, Iwakawa R, Moriguchi T,
Kiyono T, Morishita K, Sanchez-Cespedes M, Akiyama T and Yokota J:
Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of
human lung cancer cells. Lung Cancer. 70:136–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Che J, Yang Y, Xiao J, Zhao P, Yan B, Dong
S and Cao B: Decreased expression of claudin-3 is associated with a
poor prognosis and EMT in completely resected squamous cell lung
carcinoma. Tumour Biol. 36:6559–6568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang D, Duan H, Huang H, Tong X, Han Y,
Ru G, Qu L, Shou C and Zhao Z: Cisplatin resistance in gastric
cancer cells is associated with HER2 upregulation-induced
epithelial-mesenchymal transition. Sci Rep. 6:205022016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sung WJ, Kim H and Park KK: The biological
role of epithelial-mesenchymal transition in lung cancer (Review).
Oncol Rep. 36:1199–1206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edgnülü TG, Özge A, Erdal N, Kuru O and
Erdal ME: Association analysis of the functional MAOA gene promoter
and MAOB gene intron 13 polymorphisms in tension type headache
patients. Adv Clin Exp Med. 23:901–906. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nikolac Perkovic M, Svob Strac D, Nedic
Erjavec G, Uzun S, Podobnik J, Kozumplik O, Vlatkovic S and Pivac
N: Monoamine oxidase and agitation in psychiatric patients. Prog
Neuropsychopharmacol Biol Psychiatry. 69:131–146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Huang L, Luo XJ, Wu L and Li M:
MAOA Variants and genetic susceptibility to major psychiatric
disorders. Mol Neurobiol. 53:4319–4327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Voltas N, Aparicio E, Arija V and Canals
J: Association study of monoamine oxidase-A gene promoter
polymorphism (MAOA-uVNTR) with self-reported anxiety and other
psychopathological symptoms in a community sample of early
adolescents. J Anxiety Disord. 31:65–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peehl DM, Coram M, Khine H, Reese S,
Nolley R and Zhao H: The significance of monoamine oxidase-A
expression in high grade prostate cancer. J Urol. 180:2206–2211.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu JB, Shao C, Li X, Li Q, Hu P, Shi C, Li
Y, Chen YT, Yin F, Liao CP, et al: Monoamine oxidase A mediates
prostate tumorigenesis and cancer metastasis. J Clin Invest.
124:2891–2908. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu JB, Yin L, Shi C, Li Q, Duan P, Huang
JM, Liu C, Wang F, Lewis M, Wang Y, et al: MAOA-dependent
activation of Shh-IL6-RANKL signaling network promotes prostate
cancer metastasis by engaging tumor-stromal cell interactions.
Cancer Cell. 31:368–382. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stone L: Prostate cancer: Feel it in your
bones: MAOA mediates metastasis. Nat Rev Urol. 14:326–327. 2017.
View Article : Google Scholar
|
|
28
|
Lin YC, Chang YT, Campbell M, Lin TP, Pan
CC, Lee HC, Shih JC and Chang PC: MAOA - a novel decision maker of
apoptosis and autophagy in hormone refractory neuroendocrine
prostate cancer cells. Sci Rep. 7:463382017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao H, Flamand V and Peehl DM:
Anti-oncogenic and pro-differentiation effects of clorgyline, a
monoamine oxidase A inhibitor, on high grade prostate cancer cells.
BMC Med Genomics. 2:552009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu JB, Lin TP, Gallagher JD, Kushal S,
Chung LW, Zhau HE, Olenyuk BZ and Shih JC: Monoamine oxidase A
inhibitor-near-infrared dye conjugate reduces prostate tumor
growth. J Am Chem Soc. 137:2366–2374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Yang XM, Wang YH, Feng MX, Liu XJ,
Zhang YL, Huang S, Wu Z, Xue F, Qin WX, et al: Monoamine oxidase A
suppresses hepatocellular carcinoma metastasis by inhibiting the
adrenergic system and its transactivation of EGFR signaling. J
Hepatol. 60:1225–1234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang L, Frampton G, Rao A, Zhang KS, Chen
W, Lai JM, Yin XY, Walker K, Culbreath B, Leyva-Illades D, et al:
Monoamine oxidase A expression is suppressed in human
cholangiocarcinoma via coordinated epigenetic and IL-6-driven
events. Lab Invest. 92:1451–1460. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Witalison EE, Cui X, Causey CP, Thompson
PR and Hofseth LJ: Molecular targeting of protein arginine
deiminases to suppress colitis and prevent colon cancer.
Oncotarget. 6:36053–36062. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Li J, Shen J, Wang C, Yang L and
Zhang X: MicroRNA-182 downregulates metastasis suppressor 1 and
contributes to metastasis of hepatocellular carcinoma. BMC Cancer.
12:2272012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Różycka A, Słopień R, Słopień A,
Dorszewska J, Seremak-Mrozikiewicz A, Lianeri M, Maciukiewicz M,
Warenik-Szymankiewicz A, Grzelak T, Kurzawińska G, et al: The MAOA
COMT, MTHFR and ESR1 gene polymorphisms are associated with the
risk of depression in menopausal women. Maturitas. 84:42–54. 2016.
View Article : Google Scholar : PubMed/NCBI
|
